newsfilter
← Latest News
Business Wire·

Quince Therapeutics to Present at Citizens Life Sciences Conference

Quince Therapeutics, Inc. (NASDAQ:QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases, today announced that Dirk Thye, M.D., Quince's